WeightWatchers 2012 Annual Report Download - page 102

Download and view the complete annual report

Please find page 102 of the 2012 WeightWatchers annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 132

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132

WEIGHT WATCHERS INTERNATIONAL, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
Under the 2004 Plan, grants may take the following forms at the Company’s Board of Directors or its
committee’s sole discretion: non-qualified stock options, incentive stock options, stock appreciation rights,
RSUs, restricted stock and other share-based awards. As of its effective date, the maximum number of shares of
common stock available for grant under the 2004 Plan was 2,500.
Under the Stock Plans, the Company also grants fully-vested shares of its common stock to certain members
of its Board of Directors. While these shares are fully vested, beginning with stock grants made in the fourth
quarter of 2006, the directors are restricted from selling these shares while they are still serving on the
Company’s Board of Directors. During the fiscal years ended December 29, 2012, December 31, 2011
and January 1, 2011, the Company granted 13, 13, and 19 fully-vested shares, respectively, and recognized
compensation expense of $707, $772 and $595, respectively.
The Company issues common stock for share-based compensation awards from treasury stock. The total
compensation cost that has been charged against income for these plans was $8,845, $9,067 and $8,612 for the
years ended December 29, 2012, December 31, 2011 and January 1, 2011, respectively. Such amounts have been
included as a component of selling, general and administrative expenses. The total income tax benefit recognized
in the income statement for all share-based compensation arrangements was $2,742, $2,895 and $2,662 for the
years ended December 29, 2012, December 31, 2011 and January 1, 2011, respectively. The tax benefits realized
from options exercised and RSUs vested totaled $5,847, $11,309 and $516 for the years ended December 29,
2012, December 31, 2011 and January 1, 2011, respectively. No compensation costs were capitalized. As of
December 29, 2012, there was $21,461 of total unrecognized compensation cost related to stock options and
RSUs granted under the Stock Plans. That cost is expected to be recognized over a weighted-average period of
approximately 2.2 years.
While the Stock Plans permit various types of awards, other than the aforementioned shares issued to
directors, grants under the plans have historically been either non-qualified stock options or RSUs. The following
describes some further details of these awards.
Stock Option Awards
Pursuant to the option components of the Stock Plans, the Company’s Board of Directors authorized the
Company to enter into agreements under which certain employees received stock options. The options are
exercisable based on the terms outlined in the agreements. Options outstanding at December 29, 2012 vest over a
period of three to five years and the expiration term is ten years. Options outstanding at December 29, 2012 have
an exercise price between $19.74 and $79.55 per share.
The fair value of each option award is estimated on the date of grant using the Black-Scholes option pricing
model with the weighted average assumptions noted in the following table. Expected volatility is based on the
historical volatility of the Company’s stock with certain time periods excluded due to historical events which are
not expected to recur. Since the Company’s option exercise history is limited, it has estimated the expected term
of option grants to be the midpoint between the vesting period and the contractual term of each award. The risk
free interest rate is based on the U.S. Treasury yield curve in effect on the date of grant which most closely
corresponds to the expected term of the option. The dividend yield is based on our historic average dividend
yield.
F-20